GUCY2C and metastatic colorectal cancer: The intestinal epithelial, transmembrane cyclase, guanylyl cyclase C (GUCY2C), is an ideal immunotherapeutic target, because it occupies an endogenous, compartmentalized luminal niche protected from systemic autoimmune adverse events, whereas its depolarized expression on metastatic colorectal cancer can be targeted therapeutically.